Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulfatase (rhASB) enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

被引：0
|
作者：
Harmatz, P
Whitley, C
Steiner, R
Plecko, B
Kaplan, P
Waterson, J
Ketteridge, D
Giugliani, R
Schwartz, I
Guffon, N
Miranda, CS
Keppen, L
Teles, EL
Kramer, WG
Hopwood, JJ
机构：
[1] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[2] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[3] Graz Univ, Kinderklin, A-8010 Graz, Austria
[4] Childrens Hosp Philadelphia, Philadelphia, PA USA
[5] Womens & Childrens Hosp, Adelaide, SA, Australia
[6] Hospl Clin Porto Alegre, Porto Alegre, RS, Brazil
[7] Hosp Edouard Herriot, Lyon, France
[8] Univ S Dakota, Vermillion, SD 57069 USA
[9] Hosp Sao Joao, Oporto, Portugal
[10] Kramer Consulting LLC, N Potomac, MD USA
[11] Childrens Hosp & Res Ctr, Oakland, CA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2004年 / 81卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 45 条
  • [41] Induction of oral tolerance to N-acetylgalactosamine 6-sulfate sulfatase (GAINS) used for enzyme replacement therapy (ERT) in Morquio syndrome type A
    Sosa-Molano, Angela
    Kariuki, Barbara
    Knutsen, Alan
    Bellone, Clifford
    Tomatsu, Shunji
    Barrera, Luis
    Montano, Adriana
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S86 - S87
  • [42] Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-N-Acetylglucosamine-6-Sulfatase in Neonatal Mice
    Wang, Feng
    Moen, Derek R.
    Sauni, Chelsee
    Kan, Shih-hsin
    Li, Shan
    Le, Steven Q.
    Lomenick, Brett
    Zhang, Xiaoyi
    Ekins, Sean
    Singamsetty, Srikanth
    Wood, Jill
    Dickson, Patricia, I
    Chou, Tsui-Fen
    MOLECULAR PHARMACEUTICS, 2021, 18 (01) : 214 - 227
  • [43] Enzyme replacement therapy for MPS VI with recombinant human N-acetylcalactosamine, 4-sulphatase (rhASB) from 8 weeks of age - A sibling control study
    McGill, J. J.
    Inwood, A. C.
    Coman, D. J.
    Lipke, M. L.
    Skinner, J.
    Morris, B.
    Adsett, D.
    Nevin, N.
    Smith, H.
    Hopwood, J. J.
    Swiedler, S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 65 - 65
  • [44] Pilot enzyme replacement therapy with recombinant human glucosamine (N-acetyl)-6-sulfatase in mucopolysaccharidosis type IIID mouse model
    Sauni, Chelsee T.
    Wang, Feng
    Kan, Shih-Hsin
    Le, Steven Q.
    Anderson, Betty
    Wood, Jill
    Ekins, Sean
    Chou, Tsui-Fen
    Dickson, Patricia
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S125 - S125
  • [45] BMN 110 (Recombinant Human GALNS), an Investigational Enzyme Replacement Therapy for Mucopolysaccharidosis Type IVA (MPS IVA Or Morquio Syndrome), Promotes Type II Collagen Synthesis in MPS IVA Patients
    Lorget, Florence
    Lee, Sungwook
    Lau, Kelly
    Tsuruda, Laurie
    Hendriksz, Chris
    Jones, Simon
    Vellodi, Ashok
    Cheng, Sabrina
    Decker, Celeste
    O'Neill, Charles
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S44 - S44
12345